Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients

Journal of Autoimmunity

Volumn 15, Issue 1, 2000, Pages 61-66

  Valentini, Gabriele ^a   Romano, Maria Fiammetta ^a   Naclerio, Caterina ^a   Bisogni, Rita ^a   Lamberti, Annalisa ^b   Turco, Maria Caterina ^a   Venuta, Salvatore ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

CD154; Systemic sclerosis; T lymphocytes

Indexed keywords

GLYCOPROTEIN GP 39;

ADULT; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

EID: 0034457242     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0387     Document Type: Article

References (33)

1. CD40 and CD154 in cell-mediated immunity
2. The many roles of CD40 in cell-mediated inflammatory responses
3. CD40 engagement up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts
4. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide
5. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
6. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response
7. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis
8. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction
9. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells
10. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40
11. Pathogenesis: Immune aspects
12. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis
13. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
14. IL-10 inhibits nuclear factor-κB/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes
15. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets
16. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells
17. CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells
18. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
19. Increased interferon-gamma (IFN-gamma) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon
20. New perspectives on the etiology of systemic sclerosis
21. Systemic sclerosis from autoimmunity to alloimmunity
22. Systemic sclerosis: New insights in autoimmunity
23. Microchimerism: Implications for autoimmune disease
24. CD27 and (TNFR) relatives in immune system: Their role in health and disease
25. Cutting edge: Sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease
26. Increased expression of CD40 ligand on Systemic Lupus Erythematosus lymphocytes
27. Peripheral blood lymphocytes in SLE-hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells
28. Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand
29. Functional CD40L is expressed by T ceils in Rheimatoid Arthritis
30. The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation
31. Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphoctyes
32. CD40 and its crucial role as a member of the TNFR family
33. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis